BiotechTube

KUX-1151

Phase 2Completed
0 watching 0 views this week⚡ Active
51
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Hyperuricemia

Conditions

Hyperuricemia

Trial Timeline

— → —

NCT ID
NCT02190786

About KUX-1151

KUX-1151 is a phase 2 stage product being developed by Kissei Pharmaceutical for Hyperuricemia. The current trial status is completed. This product is registered under clinical trial identifier NCT02190786. Target conditions include Hyperuricemia.

Hype Score Breakdown

Clinical
17
Activity
12
Company
9
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT02190786Phase 2Completed

Competing Products

20 competing products in Hyperuricemia

See all competitors
ProductCompanyStageHype Score
SHR4640 dose1 plus Febuxostat dose1 + SHR4640 dose1 plus Febuxostat dose2 + SHR4640 dose2 plus Febuxostat dose3Jiangsu Hengrui MedicinePhase 2
52
HR091506 tablets + placebo of febuxostat tablets + febuxostat tablets + placebo of HR091506 tabletsJiangsu Hengrui MedicinePhase 1
33
SHR4640 dose1 + Febuxostat dose2Jiangsu Hengrui MedicinePhase 1
33
Placebo + SHR4640 + benzbromaroneJiangsu Hengrui MedicinePhase 2
52
SHR4640 tablet + SHR4640 tablet + febuxostat tablet + SHR4640 placebo tabletJiangsu Hengrui MedicinePhase 2
52
SHR4640Jiangsu Hengrui MedicinePhase 1
33
repaglinide; midazolam; SHR4640 + repaglinide; midazolam; SHR4640; SHR4640 placebo + repaglinide; midazolam; SHR4640 placeboJiangsu Hengrui MedicinePhase 1
33
SHR4640 + placeboJiangsu Hengrui MedicinePhase 1
33
SHR4640 ；Febuxostat + SHR4640 ; Febuxostat + SHR4640 + SHR4640 + FebuxostatJiangsu Hengrui MedicinePhase 2
52
SHR4640 + SHR4640Jiangsu Hengrui MedicinePhase 1
33
HR091506 tablets + placebo of febuxostat tablets + febuxostat tablets + placebo of HR091506 tabletsJiangsu Hengrui MedicinePhase 3
77
HR091506 tablets + placebo of febuxostat tablets + febuxostat tablets + placebo of HR091506 tabletsJiangsu Hengrui MedicinePhase 3
77
SHR4640 + PlaceboJiangsu Hengrui MedicinePhase 1
33
Verinurad + Febuxostat + DapagliflozinAstraZenecaPhase 2
52
Verinurad 9 mg+Febuxostat 80 mg + PlaceboAstraZenecaPhase 2
52
RDEA3170 + Allopurinol + PlaceboAstraZenecaPhase 2
52
RDEA3170 + Febuxostat + BenzbromaroneAstraZenecaPhase 1/2
41
Arhalofenate + Febuxostat + ColchicineGilead SciencesPhase 2
51
Arhalofenate + Arhalofenate + Placebo comparator + ColchicineGilead SciencesPhase 2
51
FYU-981 + FebuxostatMochida PharmaceuticalPhase 3
76

Other Products from Kissei Pharmaceutical

KAD-1229 + Placebo + InsulinApproved
84
Avacopan, prednisolone and rituximab + Prednisolone and rituximabApproved
84
KLH-2109 + LeuprorelinPhase 3
76
KAD-1229Phase 3
76
KUC-7483 + Placebo + TolterodinePhase 3
76